Orchid Pharma Share Price

  • 1,404.200.36 (0.03%)
  • Volume: 97,168
  • Closed
  • Last Updated On: 29 Aug, 2024, 03:51 PM IST
STOCK SCORE
ETPrime Only
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • TECHNICALS
  • COMPARE
Loading...

Orchid Pharma Share Pri...

  • 1,404.200.36 (0.03%)
  • Volume: 97,168
Advertisment

Orchid Pharma share price insights

View All

  • Company has spent 2.0% of its operating revenues towards interest expenses and 8.5% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

  • Stock gave a 3 year return of 237.87% as compared to Nifty Midcap 100 which gave a return of 112.53%. (as of last trading session)

  • Stock generated 237.87% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)

  • Orchid Pharma Ltd. share price moved up by 0.03% from its previous close of Rs 1,403.85. Orchid Pharma Ltd. stock last traded price is 1,404.20

    Share PriceValue
    Today/Current/Last1,404.20
    Previous Day1,403.851,403.70

InsightsOrchid Pharma

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		63.85
    EPS - TTM
    (₹)    		21.99
    MCap
    (₹ Cr.)    		7,121.98
    Sectoral MCap Rank
    		46
    PB Ratio
    (x)    		6.09
    Div Yield
    (%)    		0.00
    Face Value
    (₹)    		10.00
    Beta

    Beta

    1 Month0.76
    3 Months0.81
    6 Months1.21
    1 Year0.84
    3 Years1.05

    		0.76
    VWAP
    (₹)    		1,401.05
    52W H/L
    (₹)
    1,590.00 / 432.05

    Orchid Pharma Share Price Returns

    1 Day0.03%
    1 Week1.83%
    1 Month2.27%
    3 Months36.54%
    1 Year157.25%
    3 Years237.87%
    5 YearsN.A.

    ET Stock ScreenersTop Score Companies

    Check whether Orchid Pharma belongs to analysts' top-rated companies list?

    View Stock Screeners

    Orchid Pharma News & Analysis

    View all Orchid Pharma Share News & Announcements

    Orchid Pharma Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Orchid Pharma Share Recommendations

    Recent Recos

    STRONG BUY

    Current

    Mean Recos by 3 Analysts

    Strong
    Sell    SellHoldBuyStrong
    Buy

    That's all for Orchid Pharma recommendations. Check out other stock recos.

    Analyst Trends

    RatingsCurrent1 Week Ago1 Month Ago3 Months Ago
    Strong Buy2222
    Buy1111
    Hold----
    Sell----
    Strong Sell----
    # Analysts3333
    View all Stock Recommendations

    Orchid Pharma Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • Employee & Interest Expense

        Company has spent 2.0% of its operating revenues towards interest expenses and 8.5% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
      Quarterly | AnnualJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
      Total Income251.98230.46228.21207.11184.81
      Total Income Growth (%)9.340.9910.1912.07-12.67
      Total Expenses220.36196.60194.47183.28168.49
      Total Expenses Growth (%)12.081.106.108.7821.90
      EBIT31.6233.8633.7423.8316.32
      EBIT Growth (%)-6.610.3641.5846.00-77.77
      Profit after Tax (PAT)29.3532.9629.4319.809.40
      PAT Growth (%)-10.9411.9748.62110.57-84.10
      EBIT Margin (%)12.5514.6914.7811.518.83
      Net Profit Margin (%)11.6514.3012.909.565.09
      Basic EPS (₹)5.796.816.184.301.85
      Quarterly | AnnualJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
      Total Income252.18229.99228.03206.94184.81
      Total Income Growth (%)9.650.8610.1911.98-12.67
      Total Expenses219.60196.58193.94182.90168.49
      Total Expenses Growth (%)11.711.366.048.5521.90
      EBIT32.5833.4134.0824.0416.32
      EBIT Growth (%)-2.49-1.9841.7847.30-77.77
      Profit after Tax (PAT)29.1033.1930.5520.2410.78
      PAT Growth (%)-12.318.6550.9087.86-83.39
      EBIT Margin (%)12.9214.5314.9511.628.83
      Net Profit Margin (%)11.5414.4313.409.785.83
      Basic EPS (₹)5.746.866.424.402.64
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue850.23685.33568.56465.29532.53
      Total Revenue Growth (%)24.0620.5422.20-12.63-13.68
      Total Expenses758.29669.29625.46560.54663.60
      Total Expenses Growth (%)13.307.0111.58-15.53-11.33
      Profit after Tax (PAT)92.1746.32-1.95-116.53-131.07
      PAT Growth (%)98.99----288.84
      Operating Profit Margin (%)13.217.24-4.44-9.75-24.98
      Net Profit Margin (%)11.246.95-0.34-25.89-25.79
      Basic EPS (₹)19.0611.35-0.48-28.55-14.75
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue849.76685.33565.98457.17529.94
      Total Revenue Growth (%)23.9921.0923.80-13.73-11.76
      Total Expenses758.23669.29618.75553.04679.77
      Total Expenses Growth (%)13.298.1711.88-18.64-6.44
      Profit after Tax (PAT)94.7554.19-4.81-117.15-149.84
      PAT Growth (%)74.85----
      Operating Profit Margin (%)13.167.246.14-9.88-28.82
      Net Profit Margin (%)11.568.13-0.86-25.99-29.64
      Basic EPS (₹)19.5913.28-1.18-28.70-16.87

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets1,553.871,225.211,110.561,237.251,721.66
      Total Assets Growth (%)26.8310.32-10.24-28.14-44.05
      Total Liabilities384.41536.56463.18584.34697.30
      Total Liabilities Growth (%)-28.3615.84-20.73-16.20-81.56
      Total Equity1,169.47688.65647.38652.911,024.36
      Total Equity Growth (%)69.826.37-0.85-36.26-
      Current Ratio (x)3.041.351.873.873.25
      Total Debt to Equity (x)0.110.480.410.660.49
      Contingent Liabilities87.9348.7124.870.190.97
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets1,552.201,223.261,094.191,224.471,711.74
      Total Assets Growth (%)26.8911.80-10.64-28.47-42.81
      Total Liabilities333.89491.30416.24543.13655.54
      Total Liabilities Growth (%)-32.0418.03-23.36-17.15-82.51
      Total Equity1,218.32731.96677.95681.341,056.20
      Total Equity Growth (%)66.457.97-0.50-35.49-
      Current Ratio (x)3.731.512.255.384.19
      Total Debt to Equity (x)0.110.450.400.630.47
      Contingent Liabilities59.2344.9124.8745.310.97

      All figures in Rs Cr, unless mentioned otherwise

      View Details

    • Insights

      • Increase in Cash from Investing

        Company has used Rs 312.03 cr for investing activities which is an YoY increase of 899.65%. (Source: Consolidated Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities125.9918.3492.4723.5980.80
      Net Cash used in Investing Activities-312.03-31.21112.9467.21167.11
      Net Cash flow from Financing Activities167.0431.17-216.80-164.99-250.33
      Net Cash Flow-19.0018.29-11.39-74.20-2.42
      Closing Cash & Cash Equivalent3.6022.604.3115.6989.89
      Closing Cash & Cash Equivalent Growth (%)-84.06424.71-72.56-82.54-2.62
      Total Debt/ CFO (x)1.0718.072.9018.256.21
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities130.7313.3989.5724.3680.42
      Net Cash used in Investing Activities-315.81-26.70112.9367.21167.12
      Net Cash flow from Financing Activities167.0731.17-216.80-164.99-250.33
      Net Cash Flow-18.0117.86-14.30-73.42-2.79
      Closing Cash & Cash Equivalent0.2918.310.4514.7588.17
      Closing Cash & Cash Equivalent Growth (%)-98.393,966.57-96.95-83.27-3.07
      Total Debt/ CFO (x)1.0324.752.9917.666.24

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)7.886.72-0.30-17.84-12.79
      Return on Capital Employed (%)8.375.65-2.86-4.00-8.23
      Return on Assets (%)5.933.78-0.17-9.41-7.61
      Interest Coverage Ratio (x)8.653.201.94-0.86-30.52
      Asset Turnover Ratio (x)0.590.570.4836.3729.50
      Price to Earnings (x)57.8033.90-625.00-86.96-0.16
      Price to Book (x)4.532.281.7915.410.02
      EV/EBITDA (x)36.5218.1422.86161.10-350.31
      EBITDA Margin (%)17.2715.4711.1014.44-0.19
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)7.777.40-0.70-17.19-14.18
      Return on Capital Employed (%)8.035.383.80-3.96-9.26
      Return on Assets (%)6.104.42-0.43-9.56-8.75
      Interest Coverage Ratio (x)8.643.200.76-0.87-35.03
      Asset Turnover Ratio (x)0.590.570.4836.8029.52
      Price to Earnings (x)56.1828.99-243.90-86.21-0.14
      Price to Book (x)4.352.141.7114.770.02
      EV/EBITDA (x)36.7118.2221.49162.72-17.63
      EBITDA Margin (%)17.2115.4711.8914.28-3.91

    Financial InsightsOrchid Pharma

    • Income (P&L)
    • Cash Flow

      • Employee & Interest Expense

        Company has spent 2.0% of its operating revenues towards interest expenses and 8.5% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

      • Increase in Cash from Investing

        Company has used Rs 312.03 cr for investing activities which is an YoY increase of 899.65%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Orchid Pharma Share Price Forecast

    • PRICE

    • REVENUE

    • EARNINGS

    • Get multiple analysts’ prediction on Orchid Pharma

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    • Get multiple analysts’ prediction on Orchid Pharma

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    • Get multiple analysts’ prediction on Orchid Pharma

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    Orchid Pharma Peer Comparison

    • Orchid Pharma Stock Performance

    • Ratio Performance

      • CHART
      • TABLE

      Insights

      • Stock Returns vs Nifty Midcap 100

        Stock gave a 3 year return of 237.87% as compared to Nifty Midcap 100 which gave a return of 112.53%. (as of last trading session)

      • Stock Returns vs Nifty Pharma

        Stock generated 237.87% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Insights

          • Stock Returns vs Nifty Midcap 100

            Stock gave a 3 year return of 237.87% as compared to Nifty Midcap 100 which gave a return of 112.53%. (as of last trading session)

          • Stock Returns vs Nifty Pharma

            Stock generated 237.87% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)

          Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Orchid Pharma 63.856.097.888.375.9322.0113.2111.6019.063.040.111.07
          Marksans Pharma31.775.0815.1918.9711.7017.0419.9614.466.924.780.010.13
          FDC Ltd27.374.1014.5418.5512.3612.5220.6015.7018.583.590.000.00
          Blue Jet Healthcare53.5624.7940.7352.3225.9413.2439.1327.211,396.272.430.110.27
          Sun Pharma Adv Res.-18.8958.19-307.91-154.06-75.18-25.70-509.80-512.55-11.931.020.37-0.11
          Add More
          Annual Ratios (%)

          Choose from Peers

          • Shilpa Medicare
          • Aarti Pharmalabs
          • Aarti Drugs
          • Supriya Lifescience
          • Hikal Ltd

          Choose from Stocks

            See All Parameters

          Peers InsightsOrchid Pharma

          • Stock Returns vs Nifty Midcap 100

            Stock gave a 3 year return of 237.87% as compared to Nifty Midcap 100 which gave a return of 112.53%. (as of last trading session)

          • Stock Returns vs Nifty Pharma

            Stock generated 237.87% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)

          Do you find these insights useful?

          • hate it

          • meh

          • love it

          Orchid Pharma Shareholding Pattern

          • QOQ Change

          • Total Shareholdings

          • Loading...
            Showing Orchid Pharma Shareholding as on 30 Jun 2024
            Category30 Jun 202431 Mar 202431 Dec 202330 Sep 2023
            Promoters69.8469.8469.8472.40
            Pledge0.000.000.000.00
            FII1.421.964.148.08
            DII18.8217.6214.3912.34
            Mutual Funds16.9115.1810.409.76
            Others9.9110.5711.627.17
          • Showing Shareholding as on 30 Jun 2024
            CategoryNo. of SharesPercentage% Change QoQ
            Promoters3,54,19,95769.84 %0.00
            Pledge00.00 %0.00
            FII7,21,4611.42 %-0.54
            DII95,42,86718.82 %1.19
            MF85,77,52016.91 %1.73
            Others50,34,8209.91 %-0.66

          MF Ownership

          MF Ownership as on 31 July 2024

          View all Mutual Fund Schemes

          Top Searches:

          Orchid Pharma News Orchid Pharma Quarterly Results Orchid Pharma Dividend Orchid Pharma Q1 ResultsOrchid Pharma Q2 ResultsOrchid Pharma Q3 ResultsOrchid Pharma Q4 Results

          Corporate Actions

          • Orchid Pharma Board Meeting/AGM

          • Orchid Pharma Dividends

          • Others
          • Meeting DateAnnounced onPurposeDetails
            Aug 12, 2024Aug 06, 2024Board MeetingQuarterly Results
            May 23, 2024May 16, 2024Board MeetingAudited Results
            Feb 08, 2024Feb 02, 2024Board MeetingQuarterly Results
            Nov 29, 2023Oct 23, 2023POM-
            Nov 04, 2023Oct 30, 2023Board MeetingQuarterly Results
          • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
            Final30%3.0Sep 13, 2012May 15, 2012
            Final 30%3.0Jul 19, 2011May 18, 2011
            Final 100%10.0Jul 12, 2010May 28, 2010
            Final 10%1.0Sep 17, 2009Jun 30, 2009
            Final 30%3.0Sep 18, 2008May 29, 2008
          • All TypesEx-DateRecord DateAnnounced onDetails
            BonusSep 15, 2005Sep 17, 2005Jul 18, 2005Bonus Ratio: 1 share(s) for every 2 shares held
            RightsJan 09, 1995Feb 01, 1995Mar 15, 1995Rights ratio: 1 share for every 1 held at a price of Rs 40.0

          About Orchid Pharma

          Orchid Pharma Ltd., incorporated in the year 1992, is a Small Cap company (having a market cap of Rs 7,121.98 Crore) operating in Pharmaceuticals sector. Orchid Pharma Ltd. key Products/Revenue Segments include Pharmaceutical Products, Other Materials, Sale of services and Other Operating Revenue for the year ending 31-Mar-2024. Show More

          • Executives

          • Auditors

          • RG

            Ram Gopal Agarwal

            Chairman & Non-Exe.Director
            RG

            Ram Gopal Agarwal

            Chairman & Non-Exe.Director
            MD

            Manish Dhanuka

            Managing Director
            MD

            Manish Dhanuka

            Managing Director
            Show More
          • Singhi & Co.
            CNGSN & Associates LLP

          Industry

          Pharma - Indian

          Key Indices Listed on

          -

          Address

          Plot Nos. 121-128, 128A-133, 138-151, 159-164,SIDCO Industrial Estate, Alathur,Chengalpattu, Tamil Nadu - 600110

          Contact

          [email protected]

          http://www.orchidpharma.com

          More Details

          Trending in Markets

          DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

          DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

          By using this site, you agree to the Terms of Service and Privacy Policy.

          Business News›Markets›Stocks›Stock Price Quotes›Orchid Pharma Share Price
          The Economic Times